Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Dr Reddys Laboratories ADR repsg 1 Ord Shs RDY

Healthcare
Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC). Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. The... see more

Recent & Breaking News (NYSE:RDY)

Dr. Reddy's Announces the Launch of LEVALBUTEROL INHALATION SOLUTION, USP

Business Wire September 24, 2014

Dr. Reddy's Q1 FY15 Financial Results

Business Wire July 30, 2014

Dr. Reddy's to Release Q1 FY15 Results on July 30, 2014

Business Wire July 23, 2014

Dr. Reddy's Laboratories Limited Announces Filing of Annual Report on Form 20-F

Business Wire June 27, 2014

Dr. Reddy's Announces the Launch of Duloxetine Delayed-Release Capsules USP

Business Wire June 27, 2014

Dr. Reddy's announces the Launch of Paricalcitol Capsules

Business Wire June 25, 2014

Senior Level Changes at Dr. Reddy's

Business Wire May 14, 2014

Dr. Reddy's Q4 & FY14 Financial Results

Business Wire May 13, 2014

Dr. Reddy's to Release Q4 and Full Year FY14 Results on May 13, 2014

Business Wire May 1, 2014

Dr. Reddy's Announces the Launch of Fenofibrate Capsules, USP 43 mg and 130 mg

Business Wire April 23, 2014

Dr. Reddy's Announces the Launch of Eszopiclone Tablets C-IV

Business Wire April 16, 2014

Dr. Reddy's Announces the Launch of Amlodipine Besylate and Atorvastatin Calcium Tablets

Business Wire March 27, 2014

Dr. Reddy's Announces the Launch of Moxifloxacin Hydrochloride Tablets

Business Wire March 5, 2014

Dr. Reddy's Announces the Launch of Sumatriptan Injection USP, Autoinjector System

Business Wire February 26, 2014

Dr. Reddy's Q3 & 9 Months FY14 Financial Results

Business Wire February 11, 2014

Galena Biopharma and Dr. Reddy's Announce Strategic Partnership for NeuVax(TM) in India

Globe Newswire January 14, 2014

Dr. Reddy's to release Q3 FY14 results on February 11, 2014

Business Wire January 10, 2014

Dr. Reddy's Q2 & H1 FY14 Financial Results

Business Wire October 31, 2013

Dr. Reddy's to Release Q2 and Half Year FY14 Results on October 31, 2013

Business Wire October 19, 2013

Dr. Reddy's Announces the Approval of Azacitidine for Injection

Business Wire September 17, 2013